Beneficial Effects of Snail Helix aspersa Extract in an Experimental Model of Alzheimer's Type Dementia.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2022
Historique:
pubmed: 24 5 2022
medline: 8 7 2022
entrez: 23 5 2022
Statut: ppublish

Résumé

Alzheimer's disease (AD) is a complex neurodegenerative disease with multifactorial etiology, unsatisfactory treatment, and a necessity for broad-spectrum active substances for cure. The mucus from Helix aspersa snail is a mixture of bioactive molecules with antimicrobial, anti-inflammatory, antioxidant, and anti-apoptotic effects. So far there are no data concerning the capacity of snail extract (SE) to affect neurodegenerative disorders. The effects of SE from Helix aspersa on learning and memory deficits in Alzheimer's type dementia (ATD) induced by scopolamine (Sco) in male Wistar rats were examined and some mechanisms of action underlying these effects were evaluated. SE (0.5 mL/100 g) was applied orally through a food tube for 16 consecutive days: 5 days before and 11 days simultaneously with Sco (2 mg/kg, intraperitoneally). At the end of Sco treatment, using behavioral methods, we evaluated memory performance. Additionally, in cortex and hippocampus the acetylcholinesterase (AChE) activity, acetylcholine and monoamines (dopamine, noradrenaline, and serotonin) content, levels of main oxidative stress markers, and expression of brain-derived neurotrophic factor (BDNF) and cAMP response element-binding protein (CREB) were determined. We demonstrated that, according to all behavioral tests used, SE significantly improved the cognitive deficits induced by Sco. Furthermore, SE possessed AChE inhibitory activity, moderate antioxidant properties and the ability to modulate monoamines content in two brain structures. Moreover, multiple SE applications not only restored the depressed by Sco expression of CREB and BDNF, but significantly upregulated it. Summarizing results, we conclude that complex mechanisms underlie the beneficial effects of SE on impaired memory in Alzheimer's type dementia.

Sections du résumé

BACKGROUND
Alzheimer's disease (AD) is a complex neurodegenerative disease with multifactorial etiology, unsatisfactory treatment, and a necessity for broad-spectrum active substances for cure. The mucus from Helix aspersa snail is a mixture of bioactive molecules with antimicrobial, anti-inflammatory, antioxidant, and anti-apoptotic effects. So far there are no data concerning the capacity of snail extract (SE) to affect neurodegenerative disorders.
OBJECTIVE
The effects of SE from Helix aspersa on learning and memory deficits in Alzheimer's type dementia (ATD) induced by scopolamine (Sco) in male Wistar rats were examined and some mechanisms of action underlying these effects were evaluated.
METHODS
SE (0.5 mL/100 g) was applied orally through a food tube for 16 consecutive days: 5 days before and 11 days simultaneously with Sco (2 mg/kg, intraperitoneally). At the end of Sco treatment, using behavioral methods, we evaluated memory performance. Additionally, in cortex and hippocampus the acetylcholinesterase (AChE) activity, acetylcholine and monoamines (dopamine, noradrenaline, and serotonin) content, levels of main oxidative stress markers, and expression of brain-derived neurotrophic factor (BDNF) and cAMP response element-binding protein (CREB) were determined.
RESULTS
We demonstrated that, according to all behavioral tests used, SE significantly improved the cognitive deficits induced by Sco. Furthermore, SE possessed AChE inhibitory activity, moderate antioxidant properties and the ability to modulate monoamines content in two brain structures. Moreover, multiple SE applications not only restored the depressed by Sco expression of CREB and BDNF, but significantly upregulated it.
CONCLUSION
Summarizing results, we conclude that complex mechanisms underlie the beneficial effects of SE on impaired memory in Alzheimer's type dementia.

Identifiants

pubmed: 35599481
pii: JAD215693
doi: 10.3233/JAD-215693
doi:

Substances chimiques

Antioxidants 0
Brain-Derived Neurotrophic Factor 0
Cyclic AMP Response Element-Binding Protein 0
Plant Extracts 0
Scopolamine DL48G20X8X
Acetylcholinesterase EC 3.1.1.7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

155-175

Auteurs

Lyubka Tancheva (L)

Institute of Neurobiology, Bulgarian Academy of Science, Sofia, Bulgaria.
Weston Professor of Weizmann Institute of Science, Israel.

Maria Lazarova (M)

Institute of Neurobiology, Bulgarian Academy of Science, Sofia, Bulgaria.

Lyudmila Velkova (L)

Institute of Organic Chemistry with Center for Phytochemistry, Bulgarian Academy of Sciences, Sofia, Bulgaria.

Alexander Dolashki (A)

Institute of Organic Chemistry with Center for Phytochemistry, Bulgarian Academy of Sciences, Sofia, Bulgaria.

Diamara Uzunova (D)

Institute of Neurobiology, Bulgarian Academy of Science, Sofia, Bulgaria.

Borislav Minchev (B)

Institute of Neurobiology, Bulgarian Academy of Science, Sofia, Bulgaria.

Polina Petkova-Kirova (P)

Institute of Neurobiology, Bulgarian Academy of Science, Sofia, Bulgaria.

Yozljam Hassanova (Y)

Institute of Neurobiology, Bulgarian Academy of Science, Sofia, Bulgaria.

Petja Gavrilova (P)

Institute of Neurobiology, Bulgarian Academy of Science, Sofia, Bulgaria.

Krasimira Tasheva (K)

Institute of Plant Physiology and Genetics, Bulgarian Academy of Sciences, Sofia, Bulgaria.

Teodora Taseva (T)

Institute of Plant Physiology and Genetics, Bulgarian Academy of Sciences, Sofia, Bulgaria.

Yordan Hodzhev (Y)

National Center for Infectious and Parasitic Diseases, Sofia, Bulgaria.

Atanas G Atanasov (AG)

Ludwig Boltzmann Institute for Digital Health and Patient Safety, Medical University of Vienna, Vienna, Austria.
Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, Jastrzebiec, Magdalenka, Poland.
Department of Pharmaceutical Sciences, University of Vienna, Vienna, Austria.

Miroslava Stefanova (M)

Institute of Neurobiology, Bulgarian Academy of Science, Sofia, Bulgaria.

Albena Alexandrova (A)

Institute of Neurobiology, Bulgarian Academy of Science, Sofia, Bulgaria.

Elina Tzvetanova (E)

Institute of Neurobiology, Bulgarian Academy of Science, Sofia, Bulgaria.

Ventseslav Atanasov (V)

Institute of Organic Chemistry with Center for Phytochemistry, Bulgarian Academy of Sciences, Sofia, Bulgaria.

Reni Kalfin (R)

Institute of Neurobiology, Bulgarian Academy of Science, Sofia, Bulgaria.
Department of Healthcare, South-West University "Neofit Rilski", Blagoevgrad, Bulgaria.

Pavlina Dolashka (P)

Institute of Organic Chemistry with Center for Phytochemistry, Bulgarian Academy of Sciences, Sofia, Bulgaria.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH